StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.57−0.20 (-3.47%)

Close on Nov 19, 2026Market cap $3.87MP/E –Yield –

enVVeno Medical free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

enVVeno Medical's free cash flow for the twelve months ending Dec 31, 2025 was -$15.57M. For fiscal 2025 it was -$15.57M. The highest annual figure on record is -$4.21M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.57M–
FY2024Dec 31, 2024-$16.88M–
FY2023Dec 31, 2023-$18.89M–
FY2022Dec 31, 2022-$15.73M–
FY2021Dec 31, 2021-$12.22M–
FY2020Dec 31, 2020-$7.86M–
FY2019Dec 31, 2019-$6.26M–
FY2018Dec 31, 2018-$6.37M–
FY2017Dec 31, 2017-$4.21M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$3.44M–
Q3 FY2025Sep 30, 2025-$4.39M–
Q4 FY2024Dec 31, 2024-$5.11M–
Q3 FY2024Sep 30, 2024-$4.29M–
Q2 FY2024Jun 30, 2024-$3.92M–
Q1 FY2024Mar 31, 2024-$3.56M–
Q4 FY2023Dec 31, 2023-$4.98M–
Q3 FY2023Sep 30, 2023-$4.22M–
Q2 FY2023Jun 30, 2023-$4.58M–
Q1 FY2023Mar 31, 2023-$5.11M–
Q4 FY2022Dec 31, 2022-$3.87M–
Q3 FY2022Sep 30, 2022-$4.50M–
Q2 FY2022Jun 30, 2022-$3.98M–
Q1 FY2022Mar 31, 2022-$3.39M–
Q4 FY2021Dec 31, 2021-$3.17M–
Q3 FY2021Sep 30, 2021-$2.39M–
Q2 FY2021Jun 30, 2021-$2.80M–
Q1 FY2021Mar 31, 2021-$3.87M–
Q4 FY2020Dec 31, 2020-$2.64M–
Q3 FY2020Sep 30, 2020-$2.62M–
Q2 FY2020Jun 30, 2020-$1.44M–
Q1 FY2020Mar 31, 2020-$1.16M–
Q4 FY2019Dec 31, 2019-$1.64M–
Q3 FY2019Sep 30, 2019-$1.52M–
Q2 FY2019Jun 30, 2019-$1.61M–
Q1 FY2019Mar 31, 2019-$1.50M–
Q4 FY2018Dec 31, 2018-$1.45M–
Q4 FY2017Dec 31, 2017-$1.28M–
Q3 FY2017Sep 30, 2017-$1.21M–

More enVVeno Medical figures

See a number that looks wrong?